Amazon.com IncAmazon reported strongest cloud revenue growth in over four years and its custom AI chip business reached $25 billion annual run rate, indicating strong demand.
U.S. stock index futures extended gains on Friday as easing concerns over the durability of the artificial intelligence boom boosted technology shares, with Amazon leading gains after strong cloud growth helped offset fresh disappointment from Apple's cautious outlook. Amazon surged more than 12% after reporting its strongest cloud revenue growth in over four years, with its custom AI chip business reaching a $25 billion annual revenue run rate, while Apple dropped 7.3% after issuing fourth-quarter revenue guidance that fell short of Wall Street expectations. Marvell Technology rose 7% and Astera Labs gained 8% as Amazon's AI and cloud update boosted sentiment across AI infrastructure stocks. Replimune soared 125.3% after an FDA advisory committee voted 10-3 in support of the efficacy of its RP1 therapy for advanced melanoma. Roblox tumbled 16.5% on weaker-than-expected bookings growth and disappointing forward guidance, while GoDaddy fell 10.9% after issuing full-year revenue guidance below estimates and Western Union slid 7.7% after missing quarterly estimates and lowering its full-year outlook.
Amazon.com IncAmazon reported strongest cloud revenue growth in over four years and its custom AI chip business reached $25 billion annual run rate, indicating strong demand.
Apple Inc.Apple issued fourth-quarter revenue guidance below expectations, indicating weaker demand.
Astera Labs, Inc.Astera Labs gained 8% as Amazon's AI and cloud update boosted sentiment across AI infrastructure stocks, implying increased demand for its products.
Marvell Technology Group LtdMarvell Technology rose 7% as Amazon's AI and cloud update boosted sentiment across AI infrastructure stocks, implying increased demand for its products.
Roblox CorpWeaker-than-expected bookings growth and disappointing forward guidance indicate lower demand for its platform.
Replimune Group IncFDA advisory committee voted 10-3 in support of RP1 therapy efficacy, a regulatory approval step.
Western Union CoMissed quarterly estimates and lowered full-year outlook, impacting earnings expectations.
Godaddy IncGoDaddy issued full-year revenue guidance below estimates, indicating weaker demand.